Orthofix Medical Inc. (OFIX) Debt / Equity
- 2025-12-31: Debt/Equity Ratio 0.35.
- 2024-12-31: Debt/Equity Ratio 0.31.
- 2024-09-30: Debt/Equity Ratio 0.23.
- 2024-06-30: Debt/Equity Ratio 0.22.
Complete source-backed debt/equity ratio history.
- Available history
- 2023-12-31 to 2025-12-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 0.35 |
| 2024-12-31 | 0.31 |
| 2024-09-30 | 0.23 |
| 2024-06-30 | 0.22 |
| 2024-03-31 | 0.21 |
| 2023-12-31 | 0.16 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 0.35 |
| 2024-12-31 | 0.31 |
| 2023-12-31 | 0.16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |